| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | ||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | 3,9 M € | — | — | — | — | — | — | — | — | — | — | — | — | — | 29,7 k € | |||||||||||||||||
| Gross margin | 852,7 k € | -17.0% | 1,0 M € | — | 491,7 k € | -44.7% | 889,2 k € | +98.4% | 448,1 k € | +8.9% | 411,5 k € | +52.5% | 269,9 k € | +49.9% | 180,1 k € | +102.8% | 88,8 k € | -8.6% | 97,1 k € | +21.5% | 80,0 k € | +1.3% | 79,0 k € | +980.3% | -9,0 k € | -959.0% | -847,0 € | -82.2% | -465,0 € | -104.9% | 9,5 k € | |||
| EBITDA | 152,3 k € | -57.7% | 360,2 k € | -3.6% | 373,7 k € | +218.2% | 117,4 k € | -77.6% | 523,8 k € | +340.3% | 119,0 k € | -12.1% | 135,4 k € | +21.9% | 111,1 k € | +10.8% | 100,2 k € | +219.1% | 31,4 k € | -37.8% | 50,5 k € | +23.2% | 41,0 k € | +29.0% | 31,8 k € | +268.8% | -18,8 k € | -1474.6% | -1,2 k € | -47.2% | -812,0 € | -109.2% | 8,8 k € | |
| Operating profit | -51,4 k € | -129.2% | 176,2 k € | +44.0% | 122,4 k € | +342.4% | -50,5 k € | -114.2% | 354,9 k € | +1883.1% | 17,9 k € | -72.1% | 64,1 k € | +41.7% | 45,2 k € | -17.5% | 54,8 k € | +582.9% | -11,4 k € | -159.5% | 19,1 k € | +5.3% | 18,1 k € | -10.0% | 20,1 k € | +196.7% | -20,8 k € | -1641.7% | -1,2 k € | -47.2% | -812,0 € | -109.2% | 8,8 k € | |
| Profit/loss | -80,3 k € | -175.3% | 106,6 k € | +59.6% | 66,8 k € | +224.8% | -53,5 k € | -121.8% | 245,7 k € | +4782.7% | 5,0 k € | -88.3% | 43,0 k € | +57.8% | 27,2 k € | -23.8% | 35,7 k € | +396.6% | -12,1 k € | -192.5% | 13,0 k € | +1662.7% | 739,0 € | -95.8% | 17,8 k € | +185.2% | -20,9 k € | -248.9% | -6,0 k € | -706.2% | -743,0 € | -112.5% | 5,9 k € | |
| Equity | 212,8 k € | -27.4% | 293,0 k € | +57.2% | 186,4 k € | +55.9% | 119,6 k € | -30.9% | 173,2 k € | +35.9% | 127,4 k € | +4.1% | 122,4 k € | +54.1% | 79,4 k € | +52.2% | 52,2 k € | +217.6% | 16,4 k € | -42.3% | 28,5 k € | +84.3% | 15,5 k € | +5.0% | 14,7 k € | +576.7% | -3,1 k € | -117.3% | 17,8 k € | -25.2% | 23,8 k € | -3.0% | 24,5 k € | |
| Total assets | 2,6 M € | -4.9% | 2,8 M € | +63.0% | 1,7 M € | +46.3% | 1,2 M € | -28.1% | 1,6 M € | +86.8% | 868,5 k € | +3.2% | 841,5 k € | +40.2% | 600,3 k € | +38.8% | 432,4 k € | +14.8% | 376,8 k € | +53.6% | 245,3 k € | +2.3% | 239,9 k € | +75.4% | 136,8 k € | +505.5% | 22,6 k € | +25.5% | 18,0 k € | -28.0% | 25,0 k € | -15.2% | 29,5 k € | |
| Cash | 155,6 k € | +13.5% | 137,1 k € | +48.8% | 92,2 k € | +27.7% | 72,2 k € | -43.9% | 128,6 k € | +615.1% | 18,0 k € | -81.1% | 95,1 k € | +76.1% | 54,0 k € | +6.1% | 50,9 k € | +161.2% | 19,5 k € | -61.1% | 50,2 k € | +244.3% | 14,6 k € | +431.2% | 2,7 k € | -34.1% | 4,2 k € | -74.4% | 16,3 k € | -12.0% | 18,5 k € | -30.1% | 26,5 k € | |
| Debts | 2,4 M € | -2.2% | 2,5 M € | +70.4% | 1,5 M € | +43.6% | 1,0 M € | -29.1% | 1,4 M € | +100.9% | 713,1 k € | +17.6% | 606,6 k € | +26.2% | 480,8 k € | +56.6% | 307,1 k € | +19.9% | 256,1 k € | +95.5% | 131,0 k € | -27.8% | 181,4 k € | +63.7% | 110,8 k € | +331.7% | 25,7 k € | +13705.4% | 186,0 € | -84.5% | 1,2 k € | -75.8% | 5,0 k € | |
| Staff | 10,4 | 10,9 | 7,9 | 7,8 | 7,8 | 6,6 | 5,1 | 4,4 | 2,1 | 1 | 1 | 1 | 1 | 0,3 | — | — | — | |||||||||||||||||
Private limited company · Asse · incorporated on 07/08/2007 · 10,4 ETP
Private limited company loss-making in the latest fiscal year. Cash position rising (+13.5%).
Acceptable counterparty for a moderate engagement. Require 2 fiscal years of detailed accounts before any significant exposure. The abridged model hides revenue.
Half Blue is a Private limited company incorporated in 2007. Its main activity is: Wholesale of pharmaceutical goods. Its registered office is in Asse. It employs on average 10,4 ETP workers (FTE).
Key indicators
7-day free trial, no credit card required.
7-day free trial, no credit card required.
7-day free trial, no credit card required.
Source: Belgian Official Gazette